U.S. Weightlifting Athlete Regina Hancock Accepts Sanction for Anti-Doping Rule Violation

USADA announced today that Regina Hancock, of Omaha, Neb., an athlete in the sport of weightlifting, has accepted a four-year suspension for an anti-doping rule violation.

Hancock, 41, tested positive for 3′-hydroxy-stanozolol, a metabolite of stanozolol, as the result of an in-competition drug test on March 20, 2021 at the USA Masters Weightlifting Championships. Stanozolol is a Non-Specified Substance in the class of Anabolic Agents and is prohibited at all times under the USADA Protocol for Olympic and Paralympic Movement Testing, the United States Olympic and Paralympic Committee National Anti-Doping Policy, and the International Weightlifting Federation Anti-Doping Rules, all of which have adopted the World Anti-Doping Code and the World Anti-Doping Agency Prohibited List.